1-beta-d-arabinofuranosylcytosine ( ara-c ) , 2 or 3 g/sq m , was administered as a 1-hr i.v . infusion every 12 hr for 10 or 12 doses to patients with acute leukemia and refractory lymphoma .
C0010711
arabinofuranosylcytosine
C0024299
lymphoma